Interleukin 15 Primes Natural Killer Cells to Kill via NKG2D and cPLA2 and This Pathway Is Active in Psoriatic Arthritis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Tang, Fangming ^a   Sally, Benjamin ^a,b   Ciszewski, Cezary ^a   Abadie, Valerie ^a   Curran, Shane A ^a,b   Groh, Veronika ^c   FitzGerald, Oliver ^d   Winchester, Robert J ^b   Jabri, Bana ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOSOLIC PHOSPHOLIPASE A2; INTERLEUKIN 15; NATURAL KILLER CELL RECEPTOR NKG2D;

ADULT; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EFFECTOR CELL; ENVIRONMENTAL STRESS; HUMAN; HUMAN CELL; INCUBATION TIME; INNATE IMMUNITY; LARGE GRANULAR LYMPHOCYTE; NATURAL KILLER CELL; PATHOGENESIS; PHENOTYPE; PROTEIN FUNCTION; PSORIATIC ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; UPREGULATION;

ARTHRITIS, PSORIATIC; CYTOKINES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-15; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PHOSPHOLIPASES A2, CYTOSOLIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84884547502     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076292     Document Type: Article

References (29)

1. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, et al. (1996) Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 93: 12445-12450. doi:10.1073/pnas.93.22.12445. PubMed: 8901601.
2. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, et al. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress- inducible MICA [see comments]. Science 285: 727-729. doi:10.1126/science.285.5428.727. PubMed: 10426993.
3. Tang F, Chen Z, Ciszewski C, Setty M, Solus J, et al. (2009) Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med 206: 707-719. doi:10.1084/jem.20071887. PubMed: 19237603.
4. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, et al. (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-366. doi:10.1016/j.immuni.2004.06.020. PubMed: 15357947.
5. Hüe S, Mention JJ, Monteiro RC, Zhang S, Cellier C, et al. (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21: 367-377. doi:10.1016/j.immuni.2004.06.018. PubMed: 15357948.
6. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T, (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 100: 9452-9457. doi:10.1073/pnas.1632807100. PubMed: 12878725.
7. Dai Z, Turtle CJ, Booth GC, Riddell SR, Gooley TA, et al. (2009) Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus. J Exp Med 206: 793-805. doi:10.1084/jem.20081648. PubMed: 19289577.
8. Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, et al. (2007) CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 132: 2346-2358. doi:10.1053/j.gastro.2007.03.025. PubMed: 17570210.
9. Jabri B, Sollid LM, (2009) Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 9: 858-870. doi:10.1038/nri2670. PubMed: 19935805.
10. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49. doi:10.1126/science.1198687. PubMed: 21212348.
11. Perricone R, Perricone C, De Carolis C, Shoenfeld Y, (2008) NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun Rev 7: 384-390. doi:10.1016/j.autrev.2008.03.002. PubMed: 18486926.
12. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P, (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64 (Suppl 2):: ii14-ii17. doi:10.1136/ard.2004.032482. PubMed: 15708927.
13. Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, et al. (2012) HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 64: 1134-1144. doi:10.1002/art.33415. PubMed: 22006066.
14. Costello PJ, Winchester RJ, Curran SA, Peterson KS, Kane DJ, et al. (2001) Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J Immunol 166: 2878-2886. PubMed: 11160357.
15. Curran SA, FitzGerald OM, Costello PJ, Selby JM, Kane DJ, et al. (2004) Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol 172: 1935-1944. PubMed: 14734779.
16. Fitzgerald O, Winchester R, (2009) Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther 11: 214. doi:10.1186/ar2580. PubMed: 19232079.
17. McGonagle D, Benjamin M, Tan AL, (2009) The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol 21: 340-347. doi:10.1097/BOR.0b013e32832c6ab9. PubMed: 19424069.
18. de Matos CT, Berg L, Michaëlsson J, Felländer-Tsai L, Kärre K, et al. (2007) Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology 122: 291-301. doi:10.1111/j.1365-2567.2007.02638.x. PubMed: 17521371.
19. Bowness P, Ridley A, Shaw J, Chan AT, Wong-Baeza I, et al. (2011) Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 186: 2672-2680. doi:10.4049/jimmunol.1002653. PubMed: 21248258.
20. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, et al. (1995) Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 2: 439-449. doi:10.1016/1074-7613(95)90025-X. PubMed: 7749980.
21. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, et al. (1996) Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24: 406-415. PubMed: 8599969.
22. Bryceson YT, March ME, Ljunggren HG, Long EO, (2006) Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159-166. doi:10.1182/blood-2005-04-1351. PubMed: 16150947.
23. Fehniger TA, Caligiuri MA, (2001) Interleukin 15: biology and relevance to human disease. Blood 97: 14-32. doi:10.1182/blood.V97.1.14. PubMed: 11133738.
24. Waldmann TA, (2006) The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 6: 595-601. doi:10.1038/nri1901. PubMed: 16868550.
25. Roberts AI, Lee L, Schwarz E, Groh V, Spies T, et al. (2001) NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 167: 5527-5530. PubMed: 11698420.
26. Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, et al. (2003) Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 112: 1571-1580. doi:10.1172/JCI200318986. PubMed: 14617758.
27. Yokomizo T, (2011) Leukotriene B4 receptors: novel roles in immunological regulations. Adv Enzyme Regul 51: 59-64. doi:10.1016/j.advenzreg.2010.08.002. PubMed: 21035496.
28. Ueno N, Taketomi Y, Yamamoto K, Hirabayashi T, Kamei D, et al. (2011) Analysis of two major intracellular phospholipases A(2) (PLA(2)) in mast cells reveals crucial contribution of cytosolic PLA(2)alpha, not Ca(2+)-independent PLA(2)beta, to lipid mobilization in proximal mast cells and distal fibroblasts. J Biol Chem 286: 37249-37263. doi:10.1074/jbc.M111.290312. PubMed: 21880721.
29. Noordenbos T, Yeremenko N, Gofita I, van de Sande M, Tak PP, et al. (2012) Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum 64: 99-109. doi:10.1002/art.33396. PubMed: 21968742.